- Public Comps
- HealthCare Global Enterprises
HealthCare Global Enterprises Valuation Multiples
Discover HealthCare Global Enterprises' revenue and EBITDA valuation multiples and M&A history, alongside public comparables like Thomson Medical, Rhoen Klinikum, Terveystalo, Clinica Baviera and more.
HealthCare Global Enterprises Overview
About HealthCare Global Enterprises
HealthCare Global Enterprises Ltd operates in oncology, providing comprehensive cancer diagnosis and treatment services including medical oncology, radiation therapy, and surgical oncology. It also offers fertility treatment services under the Milann brand, along with multi-specialty hospital care in key medical disciplines. The company’s operations span many metropolitan and non-metro cities across India and extend internationally with cancer care centers in Africa. HCG generates revenue through patient services in oncology, fertility treatments, diagnostics, and multi-specialty hospital care, leveraging technology and a networked business model to deliver patient-centric healthcare.
Founded
1998
HQ

Employees
5.8K
Website
Sectors
Financials (LTM)
EV
$1.3B
Valuation Multiples
Start free trialHealthCare Global Enterprises Financials
HealthCare Global Enterprises reported last 12-month revenue of $279M and EBITDA of $53M.
In the same LTM period, HealthCare Global Enterprises generated $204M in gross profit, $53M in EBITDA, and $7M in net income.
Revenue (LTM)
HealthCare Global Enterprises P&L
In the most recent fiscal year, HealthCare Global Enterprises reported revenue of $265M and EBITDA of $47M.
HealthCare Global Enterprises is profitable as of last fiscal year, with gross margin of 51%, EBITDA margin of 18%, and net margin of 1%.
Financial data powered by Morningstar, Inc.
HealthCare Global Enterprises Stock Performance
HealthCare Global Enterprises has current market cap of $1.1B, and enterprise value of $1.3B.
Market Cap Evolution
HealthCare Global Enterprises' stock price is $7.59.
HealthCare Global Enterprises share price increased by 8.2% in the last 30 days, and decreased by 0.3% in the last year.
HealthCare Global Enterprises has an EPS (earnings per share) of $0.01.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $1.3B | $1.1B | -0.6% | 8.2% | 13.5% | -0.3% | $0.01 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialHealthCare Global Enterprises Valuation Multiples
HealthCare Global Enterprises trades at 4.5x EV/Revenue multiple, and 24.1x EV/EBITDA.
EV / Revenue (LTM)
HealthCare Global Enterprises Financial Valuation Multiples
As of August 23, 2026, HealthCare Global Enterprises has market cap of $1.1B and EV of $1.3B.
HealthCare Global Enterprises has a P/E ratio of 167.7x.
Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified HealthCare Global Enterprises Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.


HealthCare Global Enterprises Margins & Growth Rates
HealthCare Global Enterprises grew revenue by 14% and EBITDA by 27% in the last fiscal year.
In the most recent fiscal year, HealthCare Global Enterprises reported gross margin of 51%, EBITDA margin of 18%, and net margin of 1%.
HealthCare Global Enterprises Margins
HealthCare Global Enterprises Growth Rates
Data powered by FactSet, Inc. and Morningstar, Inc.
HealthCare Global Enterprises Operational KPIs
HealthCare Global Enterprises' revenue per employee in the last FY averaged $0.0M, while opex per employee averaged $0.0M for the same period.
HealthCare Global Enterprises' Rule of 40 is 34% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
HealthCare Global Enterprises' Rule of X is 56% (created by Bessemer, Rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
Data powered by FactSet, Inc. and Morningstar, Inc.
HealthCare Global Enterprises Competitors
HealthCare Global Enterprises competitors include Thomson Medical, Rhoen Klinikum, Terveystalo, Clinica Baviera, U.S. Physical Therapy, Al Hammadi Holding, Dr. Sulaiman Al Habib Medical Services, Life Healthcare Group, Park Medi World and Nutex Health.
Most HealthCare Global Enterprises public comparables operate across Hospitals & Clinics.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| Last FY | LTM | 2027E | Last FY | LTM | 2027E | |
| 6.4x | 5.9x | 46.4x | 34.9x | |||
| 0.3x | 0.4x | 5.6x | 5.7x | |||
| 1.2x | 1.3x | 6.7x | 6.7x | |||
| 3.0x | 2.8x | 10.6x | 9.9x | |||
| 2.4x | 2.2x | 16.8x | 18.3x | |||
| 3.5x | 3.3x | 11.6x | 12.7x | |||
| 3.1x | - | 11.6x | - | |||
| 0.8x | 0.8x | 23.5x | 5.2x | |||
This data is available for Pro users. Sign up to see all HealthCare Global Enterprises competitors and their valuation data. Start Free Trial | ||||||
Acquisitions by HealthCare Global Enterprises
HealthCare Global Enterprises has acquired 1 company to date.
Last acquisition by HealthCare Global Enterprises was on April 5th 2017. HealthCare Global Enterprises acquired Cancer Care Kenya for $900K (EV/Revenue multiple available to Pro users).
Latest Acquisitions by HealthCare Global Enterprises
| Description | Cancer Care Kenya is a Nairobi-based comprehensive cancer center founded in 2010, treating over 1,000 patients annually including 200 internationals from East Africa. The facility offers radiotherapy with Varian TrueBeam, chemotherapy, and brachytherapy in a 5,000-square-meter site. Staff speak English, Swahili, Hindi, and Gujarati, partnering with Aga Khan University for training. Cancer Care Kenya introduced PET-CT scanning in 2018, expanding palliative services. |
| HQ Country | |
| HQ City | Nairobi |
| Deal Date | 5 Apr 2017 |
| Valuation | $900K |
| EV/Revenue | |
| EV/EBITDA | |
This data is available for Pro users. Sign up to see all HealthCare Global Enterprises acquisitions and their M&A valuation multiples. Start Free Trial | |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout HealthCare Global Enterprises
| When was HealthCare Global Enterprises founded? | HealthCare Global Enterprises was founded in 1998. |
| Where is HealthCare Global Enterprises headquartered? | HealthCare Global Enterprises is headquartered in India. |
| How many employees does HealthCare Global Enterprises have? | As of today, HealthCare Global Enterprises has over 5K employees. |
| Who is the CEO of HealthCare Global Enterprises? | HealthCare Global Enterprises' CEO is Manish Mattoo. |
| Is HealthCare Global Enterprises publicly listed? | Yes, HealthCare Global Enterprises is a public company listed on National Stock Exchange of India. |
| What is the stock symbol of HealthCare Global Enterprises? | HealthCare Global Enterprises trades under HCG ticker. |
| When did HealthCare Global Enterprises go public? | HealthCare Global Enterprises went public in 2016. |
| Who are competitors of HealthCare Global Enterprises? | HealthCare Global Enterprises main competitors include Thomson Medical, Rhoen Klinikum, Terveystalo, Clinica Baviera, U.S. Physical Therapy, Al Hammadi Holding, Dr. Sulaiman Al Habib Medical Services, Life Healthcare Group, Park Medi World, Nutex Health. |
| What is the current market cap of HealthCare Global Enterprises? | HealthCare Global Enterprises' current market cap is $1.1B. |
| What is the current revenue of HealthCare Global Enterprises? | HealthCare Global Enterprises' last 12 months revenue is $279M. |
| What is the current revenue growth of HealthCare Global Enterprises? | HealthCare Global Enterprises revenue growth (NTM/LTM) is 15%. |
| What is the current EV/Revenue multiple of HealthCare Global Enterprises? | Current revenue multiple of HealthCare Global Enterprises is 4.5x. |
| What is the current EBITDA of HealthCare Global Enterprises? | HealthCare Global Enterprises' last 12 months EBITDA is $53M. |
| What is HealthCare Global Enterprises' EBITDA margin? | HealthCare Global Enterprises' last 12 months EBITDA margin is 19%. |
| What is the current EV/EBITDA multiple of HealthCare Global Enterprises? | Current EBITDA multiple of HealthCare Global Enterprises is 24.1x. |
| What is the current FCF of HealthCare Global Enterprises? | HealthCare Global Enterprises' last 12 months FCF is $7M. |
| What is HealthCare Global Enterprises' FCF margin? | HealthCare Global Enterprises' last 12 months FCF margin is 2%. |
| What is the current EV/FCF multiple of HealthCare Global Enterprises? | Current FCF multiple of HealthCare Global Enterprises is 181.5x. |
| How many companies HealthCare Global Enterprises has acquired to date? | As of August 2026, HealthCare Global Enterprises has acquired 1 company. |
| What was the largest acquisition by HealthCare Global Enterprises? | $900K acquisition of Cancer Care Kenya on 5th April 2017 was the largest M&A HealthCare Global Enterprises has done to date. |
| What companies HealthCare Global Enterprises acquired? | HealthCare Global Enterprises acquired Cancer Care Kenya. |
| In how many companies HealthCare Global Enterprises has invested to date? | HealthCare Global Enterprises hasn't invested in any companies yet (or none have been disclosed publicly). |
See public comps similar to HealthCare Global Enterprises
Lists including HealthCare Global Enterprises
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.





